Dr. Brian Halpern, MD, is the first non-surgical Fellowship Trained and Board-certified Sports Medicine Physician at Hospital for Special Surgery.
Dr. Halpern pioneered the non-operative approach to acute and chronic musculoskeletal problems. He is a founder and served as a post-President for the American Medical Society for Sports Medicine as well as the American Medical Society for Sports Medicine Foundation. He was also the past Associate Team Physician for the New York Mets. He has been on the Board of Directors of Face of America, working with disabled athletes worldwide.
In 1998, Dr. Halpern won an Emmy Award for the documentary Vietnam: Long Time Coming. He authored The Knee Crisis Handbook, which was published by Rodale Books in October, 2003, as well as the Men's Health Sports Injury Handbook, in 2005. His articles on sports-related injuries have been published in Men’s Health Magazine and other sports magazines.
One of the goals of Hospital for Special Surgery (HSS) is to advance the science of orthopedic surgery, rheumatology, and related disciplines for the benefit of patients. Physicians at HSS may collaborate with outside companies for education, research and medical advances. HSS supports this collaboration in order to foster medical breakthroughs; however HSS also believes that these collaborations must be disclosed.
As part of the disclosure process, this website lists physician collaborations with outside companies if payments were received during the prior year, or if the HSS physician currently receives payment. The disclosures are provided by information provided by the physician and other sources and are updated regularly. Further information may be available on individual company websites.
As of March 03, 2014, Dr. Halpern reported no financial interest relationships with healthcare industry.
By disclosing the collaborations of HSS physicians with industry on this website, HSS and its physicians make this information available to their patients and the public, thus creating a transparent environment for those who are interested in this information. Further, HSS’ Conflicts of Interest Policy does not permit physicians to collect royalties on products developed by him/her that are used on patients at HSS.
Research Poster Presentation Abstract: "Clinical and Magnetic Resonance Imaging Outcomes Following Platelet Rich Plasma Treatment for Elbow Tendonitis," CJSM 22(2): March 2012, page 206
Halpern B, Chaudhury S, Rodeo S. "The Role of Platelet-Rich Plasma in Inducing Musculoskeletal Tissue Healing." HSS Journal. (8) 2: 137-145. (2012).
Halpern B, Clinical and MRI outcomes after Platelet-Rich Plasma Treatment for knee Osteoarthritis, Clinical Journal of Sport Medicine, December 12, 2012The Knee Crisis Handbook, Rodale Books, 2003
For more publications, please see the PubMed listing.
Chaudhury S, Rodeo S, Warren R, Hayter C, Potter H, Nguyen J, Halpern B. "Clinical and Radiographic Outcomes Following Platelet Rich Plasma (PRP) Treatment for Elbow Epicondylitis". Poster presentation at 2012 AOSSM Annual Meeting, Baltimore -
July 12-15, 2012
Chaudhury S, Rodeo S, Warren R, Hayter C, Potter H, Nguyen J, Halpern B. "Clinical and Radiographic Outcomes Following Platelet Rich Plasma (PRP) Treatment for Elbow Epicondylitis". Poster presentation at 13th EFORT Congress, Berlin, Germany -
May 23-25, 2012
"Osteoarthritis and PRP". Podium presentation during Biologic Therapies General Session at 2012 Annual Meeting of AMSSM, Atlanta - April 22, 2012
Lecture, PRP Biologics, New York College of Podiatric Medicine - 2012, 2013
Director of Conservative Management of Knee Osteoarthritis Symposium at Hospital for Special Surgery - March 9, 2012
"Evidence for Using PRP for the Management of Knee Osteoarthritis". Podium Presentation during Conservative Management of Knee Osteoarthritis Symposium at Hospital for Special Surgery - March 9, 2012
Clinical Registry for Intra-articular of Platelet Rich Plasma (PRP) injections of Hyluronic Acid compounds Vs. usual care (exercise/diet/supplements) in the medical management of knee OA effects on pain and function: effects on articular cartilage: effects on time to partial or total knee arthroplasty: The Knee Usual Care Evaluation (KUCE) study, May 2012-present